Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy–A clinical consensus statement of the …

M Guazzi, M Wilhelm, M Halle… - European journal of …, 2022 - Wiley Online Library
Patients with heart failure with preserved ejection fraction (HFpEF) universally complain of
exercise intolerance and dyspnoea as key clinical correlates. Cardiac as well as …

MicroRNAs: midfielders of cardiac health, disease and treatment

E Asjad, H Dobrzynski - International Journal of Molecular Sciences, 2023 - mdpi.com
MicroRNAs (miRNAs) are a class of small non-coding RNA molecules that play a role in post-
transcriptional gene regulation. It is generally accepted that their main mechanism of action …

Cellular heterogeneity of the heart

N Anto Michel, S Ljubojevic-Holzer… - Frontiers in …, 2022 - frontiersin.org
Recent advances in technology such as the introduction of high throughput
multidimensional tools like single cell sequencing help to characterize the cellular …

Rate-adaptive atrial pacing for heart failure with preserved ejection fraction: the RAPID-HF randomized clinical trial

YNV Reddy, KE Koepp, R Carter, S Win, CC Jain… - JAMA, 2023 - jamanetwork.com
Importance Reduced heart rate during exercise is common and associated with impaired
aerobic capacity in heart failure with preserved ejection fraction (HFpEF), but it remains …

Cell therapy attenuates endothelial dysfunction in hypertensive rats with heart failure and preserved ejection fraction

G de Couto, T Mesquita, X Wu… - American Journal …, 2022 - journals.physiology.org
Heart failure with preserved ejection fraction (HFpEF) is defined by increased left ventricular
(LV) stiffness, impaired vascular compliance, and fibrosis. Although systemic inflammation …

Non-invasive assessment of HFpEF in mouse models: current gaps and future directions

M Villalba-Orero, P Garcia-Pavia, E Lara-Pezzi - BMC medicine, 2022 - Springer
Background Heart failure (HF) with preserved ejection fraction (HFpEF) prevalence is
increasing, and large clinical trials have failed to reduce mortality. A major reason for this …

Proteomics couples electrical remodelling to inflammation in a murine model of heart failure with sinus node dysfunction

K Kahnert, L Soattin, RW Mills, C Wilson… - Cardiovascular …, 2024 - academic.oup.com
Aims In patients with heart failure (HF), concomitant sinus node dysfunction (SND) is an
important predictor of mortality, yet its molecular underpinnings are poorly understood …

Systemic delivery of extracellular vesicles attenuates atrial fibrillation in heart failure with preserved ejection fraction

R Zhang, T Mesquita, JH Cho, C Li, L Sanchez… - Clinical …, 2023 - jacc.org
Background Atrial fibrillation (AF) is a common comorbidity in heart failure with preserved
ejection fraction (HFpEF) patients. To date, treatments for HFpEF-related AF have been …

Diastolic filling time, chronotropic response, and exercise capacity in heart failure and preserved ejection fraction with sinus rhythm

K Kagami, M Obokata, T Harada, T Kato… - Journal of the …, 2022 - Am Heart Assoc
Background Exercise‐induced high heart rate may impair exercise tolerance by reducing
diastolic filling time and ventricular filling in heart failure with preserved ejection fraction …

PDE4D mediates impaired β-adrenergic receptor signalling in the sinoatrial node in mice with hypertensive heart disease

TW Dorey, MD McRae, DD Belke… - Cardiovascular …, 2023 - academic.oup.com
Aims The sympathetic nervous system increases HR by activating β-adrenergic receptors (β-
ARs) and increasing cAMP in sinoatrial node (SAN) myocytes while phosphodiesterases …